FDA Inspection
Pacira Pharmaceuticals, Inc.Pacira Pharmaceuticals, Inc. – FDA Inspection, Mar 27, 2013
Record Details
This FDA Inspection record concerns Pacira Pharmaceuticals, Inc., with an inspection on March 27, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Pacira Pharmaceuticals, Inc.
- Inspection Date
- March 27, 2013
- Product Type
- Drugs
View Company Profile
ID · 695b6447-0e9a-4dce-8152-074894e2f02e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 825130
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Pacira Pharmaceuticals, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 25, 2026 | Not classified | Los Angeles District Office | |
| April 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2019 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| March 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pacira Pharmaceuticals, Inc.
- FDA Inspection 1316070 - 2026-03-25
- FDA Inspection 1203460 - 2023-04-19
- FDA Inspection 1102447 - 2019-09-06
- FDA Inspection 1047746 - 2018-03-01
- FDA Inspection 935306 - 2015-07-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.